Your browser doesn't support javascript.
loading
Prognostic Significance of the Severity of Immune-Related Adverse Events in Advanced Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Real-World Data Analysis.
Song, Su Jeong; Song, Yun-Kyoung; Jang, Mihwa; Shin, Eunjeong; Suh, Sung Yun; Cho, Yoon Sook; Lee, Ju-Yeun; Oh, Jung Mi.
Afiliação
  • Song SJ; Department of Pharmacy, Seoul National University Hospital, Seoul, Republic of Korea.
  • Song YK; College of Pharmacy, Daegu Catholic University, Gyeongsan-si, Gyeongbuk, Republic of Korea.
  • Jang M; Department of Pharmacy, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea.
  • Shin E; Department of Pharmacy, Seoul National University Hospital, Seoul, Republic of Korea.
  • Suh SY; Department of Pharmacy, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, United Arab Emirates.
  • Cho YS; Department of Pharmacy, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee JY; Department of Pharmacy, Seoul National University Hospital, Seoul, Republic of Korea.
  • Oh JM; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.
Target Oncol ; 18(1): 147-158, 2023 01.
Article em En | MEDLINE | ID: mdl-36515782
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article